Application of balicatib in preparation of anti-filovirus infection drugs

A technology of balicatide and filovirus, which is applied in the field of medicine and can solve the problems such as the anti-filovirus of balicatide which has not been seen

Active Publication Date: 2019-06-11
INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After searching the literature, there is no report on the anti-filovirus (includi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of balicatib in preparation of anti-filovirus infection drugs
  • Application of balicatib in preparation of anti-filovirus infection drugs
  • Application of balicatib in preparation of anti-filovirus infection drugs

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0043] Example Balikati anti-filiovirus activity

[0044] 1. Principle of screening model

[0045] The entry of filovirus into host cells is the first step of virus infection, and inhibition of virus entry can effectively block virus infection. The glycoprotein (Glycoprotein, GP) on the surface of the filovirus envelope is the key protein in the entry process of the filovirus.

[0046] The present invention applies the envelope GP gene of the filovirus, including the envelope GP gene of the Mayinga strain of Zaire Ebola virus (EBOV-Mayinga GP, Gene Accession No. L11365), and the Makona strain of the Zaire Ebola virus Envelope GP gene (EBOV-Makona GP, Gene Accession No. KJ660346.2), Sudan Ebola virus envelope GP gene (EBOV-Sudan GP, ​​Gene Accession No. FJ968794.1), Côte d’Ivoire Ebola virus Envelope GP gene (EBOV- Forest GP, Gene Accession No. FJ217162.1), Reston type Ebola virus envelope GP gene (EBOV-Reston GP, ​​Gene Accession No. U23152.1), Bundi Buccio type Ebola virus envel...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses an application of balicatib in preparation of anti-filovirus infection drugs and comprises the application of the balicatib in prevention or treatment of the filovirusinfection or the combined application with other antiviral drugs.

Description

technical field [0001] The invention relates to the application of balicatib (CAS: 354813-19-7) in anti-filovirus infection, and belongs to the technical field of medicine. The present invention includes the single or combined use of balicatib in the prevention or treatment of filoviruses. Background technique [0002] Filoviruses belong to the family Filoviridae, including three viruses: Ebola virus (EBOV), Marburg virus (Marburgvirus, MARV), and Cuevavirus (Cuevavirus, LLOV). Both Ebola virus and Marburg virus are controlled viruses and are listed as Class A bioterrorism warfare agents. Live viruses need to be operated in biosafety level 4 (P-4) laboratories [Centers for Disease Control and Prevention / National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories. 4th ed. Washington, DC: U.S. Department of Health and Human Services, U.S. Government Printing Office; 1999. DHHS Publication CDC 93-8395.]. Human infection with these two viruses can c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/495A61P31/14
Inventor 郭颖陈盼盼陈勍唐克
Owner INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap